Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Anxiety to PrevEnt Relapse in Psychosis (TAPERS)
2019-001408-39Phase 2Unknown
- Sponsor
- Cardiff University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Schizophrenia Spectrum Disorders (SSD), acute psychosis and anxiety disorder comparing Sertraline + antipsychotic with Placebo + antipsychotic (2 arms). Primary endpoint: Feasibility outcomes. Status: unknown.
02
Drugs
sertraline
03
Conditions
Schizophrenia Spectrum Disorders (SSD)acute psychosisanxiety disorder
Beyond the preview
Go deeper on 2019-001408-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001408-39.